- ConsumersReduces consumer premium burdens in 2026–2027 by lowering the maximum percent of income households must pay for exchang…
- Federal agenciesLikely increases federal subsidy spending for marketplace premium tax credits in 2026–2027 (relative to current-law PTC…
- Targeted stakeholdersImproves Medicare Advantage payment accuracy and program integrity by using two years of diagnostic data, excluding dia…
To amend the Internal Revenue Code of 1986 to extend and modify the enhanced premium tax credit, and for other purposes.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for c…
This bill (H.R. 6010) makes three main sets of changes: (1) it amends the Internal Revenue Code to set temporary premium contribution percentages for the premium tax credit for plan years 2026 and 2027 (a table of income tiers and corresponding initial and final premium percentages is specified); (2) it revises Medicare Advantage risk-adjustment rules by requiring the use of two years of diagnostic data (when available), excluding diagnoses collected from chart reviews and health risk assessments for payment adjustments, and directing the Secretary to evaluate and publicly report coding-pattern differences and account for them in adjustments; and (3) it strengthens oversight and penalties related to agent/broker-assisted enrollments in Exchange plans — adding civil and criminal penalties for negligent or knowing submission of false enrollment information, requiring verification processes for agent/broker-assisted enrollments in federally run Exchanges, expanding Secretary authority to regulate field marketing and third-party marketing organizations, and requiring audits, reporting, and a list of suspended/terminated agents and brokers.
On content alone, the bill mixes a near-term, potentially costly subsidy extension with regulatory tightening aimed at insurers and brokers. The subsidy extension is politically salient and costly, creating a significant obstacle; meanwhile the fraud‑reduction and Medicare Advantage adjustments may win some bipartisan backing but also provoke industry pushback. The need to coordinate changes across tax, Medicare, and ACA domains, plus likely controversy over fiscal impact and enforcement tools (including criminal penalties), makes enactment uncertain without broader legislative packaging or negotiated compromises.
Relative to its intended legislative type, this bill is a substantive policy measure that clearly and precisely amends multiple existing statutes to change tax-credit parameters, Medicare Advantage risk-adjustment methodology, and exchange enrollment oversight. It contains detailed statutory language, specific penalty amounts, and enumerated verification and audit requirements while delegating implementation mechanics to the relevant Secretary(ies).
Premium tax credit extension: liberals broadly support continued generosity, centrists support conditional extension with fiscal clarity, conservatives oppose added spending.
Who stands to gain, and who may push back.
- Targeted stakeholdersIncreases administrative and compliance burdens on agents, brokers, field marketing organizations, exchanges, and issue…
- ConsumersVerification requirements, delayed commission payments until inconsistencies are resolved, and stricter documentation s…
- Federal agenciesStronger penalties (large civil fines and possible criminal exposure) and expanded federal criteria for allowing market…
Why the argument around this bill splits.
Premium tax credit extension: liberals broadly support continued generosity, centrists support conditional extension with fiscal clarity, conservatives oppose added spending.
A mainstream progressive would likely view the bill as mostly positive because it extends and enhances consumer-facing premium subsidies for 2026–2027 and strengthens program integrity protections against fraudulent enrollments and potentially wasteful Medicare Advantage overpayments.
They would welcome stronger enforcement against bad actors and the consumer-notice, verification, and continuity protections included for enrollees.
At the same time, they may worry that heavy civil/criminal penalties and broad new registration/marketing submission requirements could unintentionally reduce access to trusted enrollment help in underserved communities or chill community navigators, so they would look for safeguards to protect legitimate assisters and consumers.
A pragmatic moderate would see familiar tradeoffs: the subsidy provisions preserve affordability in the short term, which is politically and socially valuable, while the Medicare Advantage and enrollment-integrity reforms aim to reduce improper payments and fraud.
They would welcome the program-integrity focus but want more clarity on costs, the fiscal impact of extending enhanced subsidies, and how penalties and regulatory requirements will be implemented to avoid disrupting enrollment assistance.
Overall, they are conditional supporters who want clearer cost estimates and careful, phased implementation.
A mainstream conservative would likely welcome the bill’s stronger fraud controls, criminal penalties for knowing fraud, and tighter oversight of marketing and brokers, and would view Medicare Advantage coding reforms favorably if they reduce overpayments.
However, they would oppose or be skeptical of continuing or expanding premium tax credit generosity, viewing it as an unnecessary and costly taxpayer subsidy that distorts markets and increases federal spending.
They would also be concerned about new federal regulatory requirements and potential centralization of authority over agents/brokers and marketing organizations.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, the bill mixes a near-term, potentially costly subsidy extension with regulatory tightening aimed at insurers and brokers. The subsidy extension is politically salient and costly, creating a significant obstacle; meanwhile the fraud‑reduction and Medicare Advantage adjustments may win some bipartisan backing but also provoke industry pushback. The need to coordinate changes across tax, Medicare, and ACA domains, plus likely controversy over fiscal impact and enforcement tools (including criminal penalties), makes enactment uncertain without broader legislative packaging or negotiated compromises.
- No legislative cost estimate or score is included in the text; the magnitude of the subsidy extension's fiscal impact is unknown from the bill alone.
- Unknown levels of support or opposition from major stakeholders (health insurers, Medicare Advantage plans, broker associations, state insurance regulators) that could materially affect legislative momentum.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Premium tax credit extension: liberals broadly support continued generosity, centrists support conditional extension with fiscal clarity, c…
On content alone, the bill mixes a near-term, potentially costly subsidy extension with regulatory tightening aimed at insurers and brokers…
Relative to its intended legislative type, this bill is a substantive policy measure that clearly and precisely amends multiple existing statutes to change tax-credit parameters, Medicare Advantage risk-adjustment metho…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.